The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
about
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesPhosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39Biochemical characterization of the core structure of alpha-synuclein filaments.17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagyGSK3 takes centre stage more than 20 years after its discovery.Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila.Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mousePseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells.Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies.Post mortem sampling of the brain and other tissues in neurodegenerative disease.Tau Aggregation Propensity Engrained in Its Solution State.Biochemistry and molecular biology of tauopathies.Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platformDivergent signaling via SUMO modification: potential for CFTR modulation.Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Emerging roles of sumoylation in the regulation of actin, microtubules, intermediate filaments, and septinsInteractions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.p38δ MAPK: Emerging Roles of a Neglected IsoformBiochemical aspects of dementias.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein.Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease.Prion disease causes less severe lesions in human hippocampus than other parts of brain.Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS.Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3β activity in rat primary cortical neurons.pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models
P2860
Q26779933-4069017F-0A38-4D3E-96C3-D0A154A402FAQ28574229-B11F60DE-CB29-4332-AC36-3FA0B0DA6B36Q30827075-BAA25C95-5C64-4EB5-B364-018A566B998BQ33525555-F355C69A-8B50-4D51-93DD-B4042B269B1DQ34374129-7E502FC4-780C-467A-B503-3F697897A8E6Q34615437-5AAA0435-B761-4640-B907-042B9CCEC92FQ34714740-FE10D942-18F3-44CC-923C-26DE46AEE2C8Q34984687-446A64D4-4091-4D33-874C-34DB9DD8B1BCQ35700412-B7B6D194-D7C1-4504-8BD5-78EF1C9CA94DQ35721063-32CE06AD-D501-42DE-BBC0-019A024ADC87Q36282762-95AC4270-731E-4E37-B6B7-C71D8A0D60CBQ36642466-D9CAF0F6-330E-404F-9555-05A8DC2456C7Q36707766-43F17E07-5A23-43EE-81F7-2B37C86E0689Q36817048-5AAD431C-22C2-48F3-A844-63C877280BCDQ36954430-4EF08267-8D7A-4AFD-9D40-351F7E26703AQ37171556-E59C52C7-63A9-4FB7-8FBE-D66CE0C2765EQ37308644-8418A3B3-4A56-4C26-8ACB-8E144B9751F4Q38215270-CF9C1BAE-6E3A-4AF9-9923-9078CD7DB945Q38260028-69BE67EE-669F-4D3E-826D-42D11F70E7EAQ38579674-34A26777-E114-4983-AC57-0B621D90EB62Q38667942-8D92F84C-9FA1-47C5-82CF-84B859C08310Q40238615-C5E0BEA6-837B-45BC-8052-355A67D335D9Q40319470-1FBE7D89-355D-4BDA-9506-2055C56FB581Q42508604-979E2E69-D27C-469F-B66C-CFE7BFFCA968Q43953401-0CBE903B-6807-440C-8335-04849B278810Q46461914-F31D7467-9219-4BF3-9A25-B757EEF8D724Q46720894-55E97494-15A2-4394-B343-5DB14F7A7B12Q52879772-3DDE5AED-0FAA-4A29-9A44-DF8AA8255552Q53264751-4C9CFB43-42E0-4DB3-B8E7-769A2FEAA910Q58762401-FD98CCA0-82BE-4F35-9518-4904E8906C2E
P2860
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@ast
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@en
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@nl
type
label
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@ast
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@en
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@nl
prefLabel
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@ast
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@en
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@nl
P1476
The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
@en
P2093
P304
P356
10.1016/S0959-437X(00)00200-8
P577
2001-06-01T00:00:00Z